TGM4: an immunogenic prostate-restricted antigen

TGM4: an immunogenic prostate-restricted antigen

Posted on by Faith
Prostate most cancers is the second main explanation for cancer-related demise in males within the USA; demise happens when sufferers progress to metastatic castration-resistant prostate most cancers (CRPC). Although immunotherapy with the Food and Drug Administration-approved vaccine sipuleucel-T, which targets prostatic acid phosphatase (PAP), extends survival for 2-Four months, the identification of latest immunogenic tumor-associated antigens (TAAs) continues to be an unmet want. 
We evaluated the differential expression profile of castration-resistant prostate epithelial cells that give rise to CRPC from mice following an androgen deprivation/repletion cycle. The expression ranges of a set of androgen-responsive genes had been additional evaluated in prostate, mind, colon, liver, lung, pores and skin, kidney, and salivary gland from murine and human databases.
The expression of a novel prostate-restricted TAA was then validated by immunostaining of mouse tissues and analyzed in major tumors throughout all human most cancers varieties in The Cancer Genome Atlas. Finally, the immunogenicity of this TAA was evaluated in vitro and in vivo utilizing autologous coculture assays with cells from wholesome donors in addition to by measuring antigen-specific antibodies in sera from sufferers with prostate most cancers (PCa) from a neoadjuvant scientific trial.
We recognized a set of androgen-responsive genes that might function potential TAAs for PCa. In specific, we discovered transglutaminase 4 (Tgm4) to be extremely expressed in prostate tumors that originate from luminal epithelial cells and solely expressed at low ranges in most extraprostatic tissues evaluated. Furthermore, elevated ranges of TGM4 expression in major PCa tumors correlated with unfavorable prognosis in sufferers. In vitro and in vivo assays confirmed the immunogenicity of TGM4.
We discovered that activated proinflammatory effector reminiscence CD8 and CD4 T cells had been expanded by monocyte-derived dendritic cell (moDCs) pulsed with TGM4 to a larger extent than moDCs pulsed with both PAP or prostate-specific antigen (PSA), and T cells primed with TGM4-pulsed moDCs produce practical cytokines following a major/enhance regiment or in vitro stimulation.
An IgG antibody response to TGM4 was detected in 30% of vaccinated sufferers, whereas fewer than 8% of vaccinated sufferers developed antibody responses to PSA or prostate-specific membrane antigen (PSMA).
TGM4: an immunogenic prostate-restricted antigen

Tissue engineered bovine saphenous vein extracellular matrix scaffolds produced through antigen elimination obtain excessive in vivo patency charges

Diseases of small diameter blood vessels embody the biggest portion of cardiovascular illnesses, with over 4.2 million folks present process autologous vascular grafting yearly. However, roughly one third of sufferers are ineligible for autologous vascular grafting resulting from lack of appropriate donor vasculature. Acellular extracellular matrix (ECM) scaffolds derived from xenogeneic vascular tissue have potential to function splendid biomaterials for manufacturing of off-the-shelf vascular graft able to eliminating the necessity for autologous vessel harvest.

A modified antigen elimination tissue (AR) course of, using aminosulfabetaine-16 (ASB-16) was used to create off-the-shelf small diameter (< three mm) vascular graft from bovine saphenous vein ECM scaffolds with considerably lowered antigenic content material, whereas retaining native vascular ECM protein construction and performance.

Elimination of native tissue antigen content material conferred graft-specific adaptive immune avoidance, whereas retention of native ECM protein macromolecular construction resulted in pro-regenerative mobile infiltration, ECM turnover and innate immune self-recognition in a rabbit subpannicular mannequin. Finally, retention of the fragile vascular basement membrane protein integrity conferred endothelial cell repopulation and 100% patency fee in a rabbit jugular interposition mannequin, comparable solely to Autograft implants.

Alternatively, the dearth of those necessary basement membrane proteins in in any other case similar scaffolds yielded a patency fee of solely 20%. We conclude that acellular antigen eliminated bovine saphenous vein ECM scaffolds have potential to function splendid off-the-shelf small diameter vascular scaffolds with excessive in vivo patency charges resulting from their low antigen content material, retained native tissue basement membrane integrity and preserved native ECM construction, composition and practical properties.

Nanoparticle Transfer Biosensors for the Non-Invasive Detection of SARS-CoV-2 Antigens Trapped in Surgical Face Masks

Detecting SARS-CoV-2 antigens in respiratory tract samples has turn out to be a widespread methodology for screening new SARS-CoV-2 infections. This requires a nasopharyngeal swab carried out by a skilled healthcare employee, which places pressure on saturated healthcare providers. In this manuscript we describe a brand new strategy for non-invasive COVID-19 analysis.

It consists of utilizing cellular biosensors for detecting viral antigens trapped in surgical face masks worn by sufferers. The biosensors are product of filter paper containing a nanoparticle reservoir. The nanoparticles switch from the biosensor to the masks on contact, the place they generate colorimetric indicators which might be quantified with a smartphone app.

Sample assortment requires sporting a surgical masks for 30 minutes, and the overall assay time is shorter than 10 min. When examined in a cohort of 27 sufferers with gentle or no signs, an space below the receiving working curve (AUROC) of 0.99 was obtained (96.2% sensitivity and 100% specificity). Serial measurements revealed a excessive sensitivity and specificity when masks had been worn as much as 6 days after analysis.

Surgical face masks are cheap and extensively accessible, which makes this strategy simple to implement wherever. Recent SARS-CoV-2 outbreak has been declared as a world well being emergency. It takes years to vaccinate the entire inhabitants to guard them from this lethal virus, therefore the administration of SARS-CoV-2 largely depends upon the widespread availability of an correct diagnostic check.

Towards addressing the unmet want of a dependable diagnostic check within the present work by using the ability of Systematic Evolution of Ligands by EXponential enrichment, a 44-mer G-quadruplex forming DNA aptamer towards spike trimer antigen of SARS-CoV-2 was recognized.

OPEF01327-1MG - Rubella Virus Antigen
OPEF01327-1MG Aviva Systems Biology 1mg 1589 EUR

Rubella virus core antigen Antibody
GWB-86609B GenWay Biotech 0.1 mg Ask for price

Rubella virus E2 recombinant antigen
00216-V-01mg Virogen 0,1 mg 321 EUR
Description: Rubella virus E2 recombinant antigen a.a. 31-105.

Rubella virus E2 recombinant antigen
00216-V-1000ug Virogen 1000 ug 1539 EUR
Description: Rubella virus E2 recombinant antigen a.a. 31-105.

Rubella Virus, Grade III Antigen >60%
MBS568752-1mL MyBiosource 1mL 590 EUR

Rubella Virus, Grade III Antigen >60%
MBS568752-5x1mL MyBiosource 5x1mL 2380 EUR

Rubella Virus Core Antigen Antibody (FITC)
GWB-8C23D0 GenWay Biotech 1 ml Ask for price

Rubella virus E1 mosaic recombinant antigen
00215-V-01mg Virogen 0,1 mg 321 EUR
Description: Rubella virus E1 mosaic recombinant antigen a.a. 157-176/374-390/213-239.

Rubella virus E1 mosaic recombinant antigen
00215-V-1000ug Virogen 1000 ug 1539 EUR
Description: Rubella virus E1 mosaic recombinant antigen a.a. 157-176/374-390/213-239.

Rubella virus capsid (C) recombinant antigen
00217-V-01mg Virogen 0,1 mg 321 EUR
Description: Rubella virus capsid (C) recombinant antigen a.a. 1-123.

Rubella virus capsid (C) recombinant antigen
00217-V-1000ug Virogen 1000 ug 1539 EUR
Description: Rubella virus capsid (C) recombinant antigen a.a. 1-123.

Rubella virus E2 recombinant antigen a.a. 31-105.
00216-V Virogen 1 MG 850 EUR

Rubella virus E2 recombinant antigen a.a. 31-105.
00216-V-100ugvial Virogen 100 ug/vial 150 EUR
Description: Rubella virus E2 recombinant antigen a.a. 31-105.

Rubella virus E2 recombinant antigen a.a. 31-105.
MBS485178-01mg MyBiosource 0.1mg 300 EUR

Rubella virus E2 recombinant antigen a.a. 31-105.
MBS485178-1mg MyBiosource 1mg 1300 EUR

Rubella virus E2 recombinant antigen a.a. 31-105.
MBS485178-5x1mg MyBiosource 5x1mg 5795 EUR

OPEF01370-1ML - Rubella Virus, Grade III Antigen
OPEF01370-1ML Aviva Systems Biology 1ml 524 EUR

Rubella virus capsid (C) recombinant antigen a.a. 1-123.
00217-V Virogen 1 MG 850 EUR

Rubella virus capsid (C) recombinant antigen a.a. 1-123.
00217-V-100ugvial Virogen 100 ug/vial 150 EUR
Description: Rubella virus capsid (C) recombinant antigen a.a. 1-123.

Rubella virus capsid (C) recombinant antigen a.a. 1-123.
MBS485177-01mg MyBiosource 0.1mg 300 EUR

Rubella virus capsid (C) recombinant antigen a.a. 1-123.
MBS485177-1mg MyBiosource 1mg 1300 EUR

Rubella virus capsid (C) recombinant antigen a.a. 1-123.
MBS485177-5x1mg MyBiosource 5x1mg 5795 EUR

Rubella virus
8806 Virostat 100 ug 380 EUR
Description: E1

Rubella virus
8807 Virostat 100 ug 380 EUR
Description: E2

Rubella virus
1714 Virostat 100 ug 270 EUR
Description: E1 glycoprotein

Rubella virus
1715 Virostat 100 ug 270 EUR
Description: E1 glycoprotein

Rubella virus
1717 Virostat 100 ug 270 EUR
Description: E2 glycoprotein

Rubella virus
1701 Virostat 1 ml 225 EUR
Description: virions

Rubella virus
MBS320344-01mg MyBiosource 0.1mg 355 EUR

Rubella virus
MBS320344-5x01mg MyBiosource 5x0.1mg 1500 EUR

Rubella virus
MBS320345-01mg MyBiosource 0.1mg 355 EUR

Rubella virus
MBS320345-5x01mg MyBiosource 5x0.1mg 1500 EUR

Rubella virus
MBS320346-01mg MyBiosource 0.1mg 355 EUR

Rubella virus
MBS320346-5x01mg MyBiosource 5x0.1mg 1500 EUR

Rubella virus
MBS320347-01mg MyBiosource 0.1mg 355 EUR

Rubella virus
MBS320347-5x01mg MyBiosource 5x0.1mg 1500 EUR

Rubella virus
MBS328056-01mg MyBiosource 0.1mg 475 EUR

Rubella virus
MBS328056-5x01mg MyBiosource 5x0.1mg 2060 EUR

Rubella virus
MBS328057-01mg MyBiosource 0.1mg 475 EUR

Rubella virus
MBS328057-5x01mg MyBiosource 5x0.1mg 2060 EUR

Rubella virus
MBS324116-1mL MyBiosource 1mL 315 EUR

Rubella virus
MBS324116-5x1mL MyBiosource 5x1mL 1320 EUR

Rubella virus
MBS324117-1mL MyBiosource 1mL 325 EUR

Rubella virus
MBS324117-5x1mL MyBiosource 5x1mL 1375 EUR

Rubella virus
MBS324118-1mL MyBiosource 1mL 345 EUR

Rubella virus
MBS324118-5x1mL MyBiosource 5x1mL 1465 EUR

Rubella virus
MBS324119-1mL MyBiosource 1mL 325 EUR

Rubella virus
MBS324119-5x1mL MyBiosource 5x1mL 1375 EUR

Rubella virus
Oneq-H481-OneqH481100R Bioingentech Oneq-H481-100R 1028 EUR

Rubella virus
Oneq-H481-OneqH481150R Bioingentech Oneq-H481-150R 1438 EUR

Rubella virus
Oneq-H481-OneqH48150R Bioingentech Oneq-H481-50R 728 EUR

Rubella virus
PCR-H481-PCRH48148R Bioingentech PCR-H481-48R 485 EUR

Rubella virus
PCR-H481-PCRH48196R Bioingentech PCR-H481-96R 685 EUR

Rubella virus antibody
10R-R119a Fitzgerald 1 mg 444 EUR
Description: Mouse monoclonal Antibody raised against Rubella virus

Rubella virus antibody
20-RG04 Fitzgerald 1 ml 360 EUR
Description: Goat polyclonal Rubella virus antibody

Rubella Virus Antibody
abx023129-1ml Abbexa 1 ml 644.4 EUR

Rubella Virus Antibody
abx023129-400l Abbexa 400 µl Ask for price

Rubella Virus Antibody
abx023129-80l Abbexa 80 µl 975 EUR

RUBELLA Virus Antibody
GWB-E871A4 GenWay Biotech 0.2 mg Ask for price

Rubella Virus, Antibody
GWB-D84015 GenWay Biotech 1 mg Ask for price

Rubella virus Antibody
GWB-60F0D7 GenWay Biotech 0.1 mg Ask for price

Rubella Virus Antibody
GWB-3BEA8B GenWay Biotech 1 mg Ask for price

Rubella Virus Antibody
MBS568453-05mL MyBiosource 0.5mL 300 EUR

Rubella Virus Antibody
MBS568453-5x05mL MyBiosource 5x0.5mL 1160 EUR

Rubella virus antibody
MBS534728-1mL MyBiosource 1mL 530 EUR

Rubella virus antibody
MBS534728-5x1mL MyBiosource 5x1mL 2235 EUR

Rubella Virus E1 Antibody
abx022204-1mg Abbexa 1 mg 718.8 EUR

Rubella Virus E1 Antibody
abx022205-1mg Abbexa 1 mg 610.8 EUR

Rubella Virus E1 Antibody
abx022206-1mg Abbexa 1 mg 610.8 EUR

Rubella Virus E1 Antibody
abx022206-400l Abbexa 400 µl Ask for price

Rubella Virus E1 Antibody
abx022206-80l Abbexa 80 µl 550 EUR

Rubella virus antibody (HRP)
60-RG05 Fitzgerald 1 ml 405 EUR
Description: Goat polyclonal Rubella virus antibody (HRP) conjugated

Rubella Virus Antibody (HRP)
abx023126-1ml Abbexa 1 ml 718.8 EUR

Rubella Virus Antibody (HRP)
abx023126-400l Abbexa 400 µl Ask for price

Rubella Virus Antibody (HRP)
abx023126-80l Abbexa 80 µl 1112.5 EUR

Rubella virus antibody (HRP)
MBS534445-1mL MyBiosource 1mL 605 EUR

Rubella virus antibody (HRP)
MBS534445-5x1mL MyBiosource 5x1mL 2570 EUR

Rubella Virus E2,
GWB-70779B GenWay Biotech 1 mg Ask for price

Rubella Virus C
GWB-77F49F GenWay Biotech 1 mg Ask for price

Rubella virus antibody (FITC)
60-RG04 Fitzgerald 1 ml 385 EUR
Description: Goat polyclonal Rubella virus antibody (FITC) conjugated

Rubella Virus Antibody (FITC)
abx023127-1ml Abbexa 1 ml 661.2 EUR

Rubella Virus Antibody (FITC)
abx023127-400l Abbexa 400 µl Ask for price

Rubella Virus Antibody (FITC)
abx023127-80l Abbexa 80 µl 1112.5 EUR

Rubella virus antibody (FITC)
MBS534714-1mL MyBiosource 1mL 560 EUR

Rubella virus antibody (FITC)
MBS534714-5x1mL MyBiosource 5x1mL 2370 EUR

Rubella Virus -HRP
GWB-7ABC27 GenWay Biotech 1 ml Ask for price

Rubella Virus IgG
RUBG0400 Demeditec Diagnostics 96 98 EUR

Rubella VIrus -FITC
GWB-143373 GenWay Biotech 1 ml Ask for price

Rubella virus E1 mosaic recombinant antigen a.a. 157-176/374-390/213-239.
00215-V Virogen 1 MG 850 EUR

Rubella virus E1 mosaic recombinant antigen a.a. 157-176/374-390/213-239.
00215-V-100ugvial Virogen 100 ug/vial 150 EUR
Description: Rubella virus E1 mosaic recombinant antigen a.a. 157-176/374-390/213-239.

Rubella virus E1 mosaic recombinant antigen a.a. 157-176/374-390/213-239.
MBS485151-01mg MyBiosource 0.1mg 300 EUR

Rubella virus E1 mosaic recombinant antigen a.a. 157-176/374-390/213-239.
MBS485151-1mg MyBiosource 1mg 1300 EUR

Rubella virus E1 mosaic recombinant antigen a.a. 157-176/374-390/213-239.
MBS485151-5x1mg MyBiosource 5x1mg 5795 EUR

NATIVE RUBELLA VIRUS
GWB-DA7089 GenWay Biotech 1 ml Ask for price

Rubella virus protein
30-1344 Fitzgerald 1 ml 497 EUR
Description: Purified native Rubella virus protein (Grade III)

Rubella Virus Protein
abx670270-1mg Abbexa 1 mg 1212 EUR

Rubella Virus Protein
abx670271-1mg Abbexa 1 mg 2163.6 EUR

Rubella Virus Vaccine
VAC-0323 Creative BioMart 0.5ml 1598.4 EUR
Description: Protein

Rubella Virus Virion Antibody
GWB-2DDE26 GenWay Biotech 1 ml Ask for price

Rubella Virus Virions Antibody
GWB-CDDDE8 GenWay Biotech 1 ml Ask for price

Rubella virus PCR kit
PCR-H481-48R Bioingentech 50T 987.6 EUR

Rubella virus PCR kit
PCR-H481-96R Bioingentech 100T 1335.6 EUR

Rubella Virus E1 mosaic
GWB-9E07D0 GenWay Biotech 1 mg Ask for price

Rubella Virus IgG ELISA
MBS495665-5x96Tests MyBiosource 5x96Tests 2420 EUR

Rubella Virus IgG ELISA
MBS495665-96Tests MyBiosource 96Tests 530 EUR

Rubella Virus E1 Mosaic
MBS555862-01mg MyBiosource 0.1mg 340 EUR

Rubella Virus E1 Mosaic
MBS555862-05mg MyBiosource 0.5mg 810 EUR

Rubella Virus E1 Mosaic
MBS555862-5x05mg MyBiosource 5x0.5mg 3495 EUR

Rubella Virus Capsid C
MBS555863-01mg MyBiosource 0.1mg 340 EUR

Rubella Virus Capsid C
MBS555863-05mg MyBiosource 0.5mg 810 EUR

Rubella Virus Capsid C
MBS555863-5x05mg MyBiosource 5x0.5mg 3495 EUR

Rubella Virus E1 Mosaic
PR27125 Neuromics 500 ug 197.1 EUR

Rubella Virus E1 Mosaic
PR27125-B Neuromics each 540 EUR

Rubella Virus Capsid C
PR27126 Neuromics 500 ug 197.1 EUR

Rubella Virus Capsid C
PR27126-B Neuromics each 540 EUR

Rubella Virus E1 protein
80-1059 Fitzgerald 1 mg 1680 EUR
Description: Purified recombinant Rubella Virus E1 protein

Rubella virus E2 protein
30-1281 Fitzgerald 1 mg 1195 EUR
Description: Purified recombinant Rubella virus E2 protein

Rubella virus E2 protein
DAGA-498 Creative Diagnostics 1mg 2337.3 EUR
Description: Recombinant

Rubella Virus E2 Protein
20-abx260148 Abbexa
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 0.5 mg
  • 1 mg

Rubella Virus E2 Protein
abx260148-20g Abbexa 20 µg 950 EUR

Rubella Virus E2 Protein
abx260148-5g Abbexa 5 µg 350 EUR

Rubella Virus E2 Protein
abx060648-1mg Abbexa 1 mg 2055.6 EUR

Rubella Virus E2 Protein
abx060649-1mg Abbexa 1 mg 1713.6 EUR

Rubella Virus E1 protein
MBS5304381-1mg MyBiosource 1mg 3075 EUR

Rubella Virus E1 protein
MBS5304381-5x1mg MyBiosource 5x1mg 13685 EUR

Goat anti Rubella Virus Virion
MBS315184-1mL MyBiosource 1mL 885 EUR

Goat anti Rubella Virus Virion
MBS315184-5x1mL MyBiosource 5x1mL 3815 EUR

Recombinant Rubella Virus E2
7-07861 CHI Scientific 100µg Ask for price

Recombinant Rubella Virus E2
7-07862 CHI Scientific 500µg Ask for price

Recombinant Rubella Virus E2
7-07863 CHI Scientific 1000µg Ask for price

Rubella Virus E2 (Recombinant)
22060684-1 Bio-WORLD 100 µg 344.89 EUR

Rubella Virus Capsid Protein
abx060645-1mg Abbexa 1 mg 2180.4 EUR

Rubella Virus IgG Immunoblot
GWB-521231 GenWay Biotech 1x96 Assays Ask for price

Rubella Virus (German Measles)
GWB-1B7BFC GenWay Biotech 1 ml Ask for price

recombinant Rubella Virus E1
E4A10F30-E1 EnoGene 100ug 595 EUR

Rubella Virus E2, Recombinant
MBS319117-1mg MyBiosource 1mg 1305 EUR

Rubella Virus E2, Recombinant
MBS319117-5x1mg MyBiosource 5x1mg 5770 EUR

Recombinant Rubella Virus E2
MBS143132-01mg MyBiosource 0.1mg 330 EUR

Recombinant Rubella Virus E2
MBS143132-05mg MyBiosource 0.5mg 825 EUR

Recombinant Rubella Virus E2
MBS143132-1mg MyBiosource 1mg 1260 EUR

Recombinant Rubella Virus E2
MBS143132-5x1mg MyBiosource 5x1mg 5345 EUR

Rubella Virus E2 Recombinant
rAP-5458 Angio Proteomie Inquiry Ask for price

Rubella Virus Avidity Reagent
B129AVID Genovis AB 1 mL 85 EUR

Rubella Virus Avidity Reagent
MBS198108-1mL MyBiosource 1mL 155 EUR

Rubella Virus Avidity Reagent
MBS198108-5x1mL MyBiosource 5x1mL 690 EUR

Rubella virus RT PCR kit
RTq-H481-100R Bioingentech 100T 1573.2 EUR

Rubella virus RT PCR kit
RTq-H481-150R Bioingentech 150T 2144.4 EUR

Rubella virus RT PCR kit
RTq-H481-50R Bioingentech 50T 1155.6 EUR

Rubella Virus IgG quantitative
GWB-31CB3E GenWay Biotech 1x96 Assays Ask for price

Rubella virus-like particles
REC32047-100 The Native Antigen Company 0.1 504.63 EUR
Description:
Rubella virus-like particles produced in a HEK293 stable cell line. Particles are secreted into the culture supernatant from stably transfected cells and purified by isopycnic centrifugation.

Rubella virus-like particles
REC32047-500 The Native Antigen Company 0.5 2144.68 EUR
Description:
Rubella virus-like particles produced in a HEK293 stable cell line. Particles are secreted into the culture supernatant from stably transfected cells and purified by isopycnic centrifugation.

Rubella Virus Core Protein Antibody
GWB-T00630 GenWay Biotech 1 mg Ask for price

Human Rubella Virus Antibody ELISA Kit
MBS3802070-10x96StripWells MyBiosource 10x96-Strip-Wells 6725 EUR

Human Rubella Virus Antibody ELISA Kit
MBS3802070-48StripWells MyBiosource 48-Strip-Wells 550 EUR

Human Rubella Virus Antibody ELISA Kit
MBS3802070-5x96StripWells MyBiosource 5x96-Strip-Wells 3420 EUR

Human Rubella Virus Antibody ELISA Kit
MBS3802070-96StripWells MyBiosource 96-Strip-Wells 765 EUR

Rubella Virus Capsid, Recombinant
MBS319093-1mg MyBiosource 1mg 1655 EUR

Rubella Virus Capsid, Recombinant
MBS319093-5x1mg MyBiosource 5x1mg 7275 EUR

QPCR Kit RNA Rubella virus
MOL8312 Scientific Laboratory Supplies EACH 788.88 EUR

Rubella Virus Capsid Protein Antibody
abx022208-1mg Abbexa 1 mg 610.8 EUR

Rubella Virus Capsid Protein Antibody
abx022208-400l Abbexa 400 µl Ask for price

Rubella Virus Capsid Protein Antibody
abx022208-80l Abbexa 80 µl 550 EUR

Rubella Virus Capsid Protein Antibody
GWB-751C39 GenWay Biotech 0.2 mg Ask for price

Recombinant Rubella virus protein
NBP0413 Bioworld Biotech each 428 EUR
Description: RV

Rubella Virus IgG ELISA Kit
ESR129G Genovis AB 96 Tests 362 EUR

Rubella Virus IgM ELISA Kit
ESR129M Genovis AB 96 Tests 362 EUR

The lead aptamer candidate (S14) was characterised totally for its binding, selectivity, affinity, construction and batch-to-batch variability by using various-biochemical, biophysical, and in silico methods. S14 has demonstrated a low nanomolar Okayd, confirming its tight binding to a spike antigen of SARS-CoV-2. S14 can detect as little as 2 nM of antigen.

Leave a Reply

Your email address will not be published.